T. Shaw

692 total citations
15 papers, 492 citations indexed

About

T. Shaw is a scholar working on Rheumatology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, T. Shaw has authored 15 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 7 papers in Pathology and Forensic Medicine and 5 papers in Genetics. Recurrent topics in T. Shaw's work include Rheumatoid Arthritis Research and Therapies (11 papers), Lymphoma Diagnosis and Treatment (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). T. Shaw is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (11 papers), Lymphoma Diagnosis and Treatment (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). T. Shaw collaborates with scholars based in United States, Germany and Canada. T. Shaw's co-authors include Andrea Rubbert‐Roth, Charles Peterfy, Ronald van Vollenhoven, Paul P. Tak, E. Hessey, William Stohl, William F. C. Rigby, Helen E.J. Tyrrell, G. Armstrong and Neil Collinson and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Clinical Immunology.

In The Last Decade

T. Shaw

13 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Shaw United States 6 381 152 137 134 104 15 492
Uta Engling Poulsen Denmark 4 514 1.3× 159 1.0× 167 1.2× 172 1.3× 98 0.9× 5 603
Jesús Tornero-Molina Spain 7 466 1.2× 98 0.6× 122 0.9× 215 1.6× 79 0.8× 15 598
Jeffrey Box United States 3 336 0.9× 112 0.7× 137 1.0× 177 1.3× 58 0.6× 5 445
Ayanbola Elegbe United States 8 308 0.8× 104 0.7× 116 0.8× 142 1.1× 80 0.8× 22 424
E. C. Hsia United States 5 481 1.3× 126 0.8× 140 1.0× 265 2.0× 69 0.7× 34 546
Juan Antonio Martínez-López Spain 8 225 0.6× 83 0.5× 100 0.7× 64 0.5× 90 0.9× 16 392
Victoria Bejarano United Kingdom 9 469 1.2× 87 0.6× 256 1.9× 197 1.5× 43 0.4× 10 650
Hjalmar Wadström Sweden 6 230 0.6× 88 0.6× 81 0.6× 56 0.4× 121 1.2× 9 340
E. Keystone Canada 8 259 0.7× 59 0.4× 86 0.6× 108 0.8× 70 0.7× 26 357
Gerd R. Burmester Germany 3 172 0.5× 53 0.3× 148 1.1× 52 0.4× 48 0.5× 4 301

Countries citing papers authored by T. Shaw

Since Specialization
Citations

This map shows the geographic impact of T. Shaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Shaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Shaw more than expected).

Fields of papers citing papers by T. Shaw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Shaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Shaw. The network helps show where T. Shaw may publish in the future.

Co-authorship network of co-authors of T. Shaw

This figure shows the co-authorship network connecting the top 25 collaborators of T. Shaw. A scholar is included among the top collaborators of T. Shaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Shaw. T. Shaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Dei, George J. Sefa, et al.. (2024). Resiliency against food insecurity among the Black population in Scarborough during the COVID-19 pandemic. Agriculture & Food Security. 13(1).
2.
3.
Kapetanovic, Meliha C, Mats Andersson, A. Friedman, et al.. (2020). SAT0145 EFFICACY AND SAFETY OF UPADACITINIB MONOTHERAPY IN MTX-NAÏVE PATIENTS WITH EARLY ACTIVE RA RECEIVING TREATMENT WITHIN 3 MONTHS OF DIAGNOSIS: A POST-HOC ANALYSIS OF THE SELECT-EARLY. Annals of the Rheumatic Diseases. 79. 1011–1011. 5 indexed citations
4.
Cohen, Stanley, Ronald van Vollenhoven, Jeffrey R. Curtis, et al.. (2020). THU0197 SAFETY PROFILE OF UPADACITINIB UP TO 3 YEARS OF EXPOSURE IN PATIENTS WITH RHEUMATOID ARTHRITIS. Annals of the Rheumatic Diseases. 79. 319–320. 12 indexed citations
5.
6.
Vollenhoven, Ronald van, Robin K. Dore, Heidi S. Camp, et al.. (2018). SAT0244 Impact of 12 weeks of upadacitinib treatment on individual and composite disease measures in patients with rheumatoid arthritis and inadequate response to conventional synthetic or biologic dmards. Annals of the Rheumatic Diseases. 77. 984–984. 1 indexed citations
7.
FitzGerald, Oliver, et al.. (2018). SAT0239 Rapid response with upadacitinib treatment in patients with rheumatoid arthritis and an inadequate response to csdmards or bdmards. Annals of the Rheumatic Diseases. 77. 981–981. 2 indexed citations
8.
Chirivi, Renato G.S., et al.. (2018). OP0318 Netosis-inhibiting t-acpa therapy for use in different net-driven human autoimmune diseases. Annals of the Rheumatic Diseases. 77. 205–205. 3 indexed citations
9.
Peterfy, Charles, Paul Emery, Mikkel Østergaard, et al.. (2011). Rituximab (RTX) plus Methotrexate (MTX) prevents bone erosion and joint-space narrowing (JSN) and reduces synovitis, osteitis as shown on MRI: Results from a randomised, placebo-controlled trial in patients (PTS) with rheumatoid arthritis (RA-score). Annals of the Rheumatic Diseases. 70. 16 indexed citations
10.
Tak, Paul P., William F. C. Rigby, Andrea Rubbert‐Roth, et al.. (2010). Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial. Annals of the Rheumatic Diseases. 70(1). 39–46. 230 indexed citations
11.
Rubbert‐Roth, Andrea, P. P. Tak, Cristiano A. F. Zerbini, et al.. (2010). Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR). Lara D. Veeken. 49(9). 1683–1693. 139 indexed citations
12.
Shaw, T., et al.. (2010). Transition of Adolescents to Young Adulthood for Vulnerable Populations. Pediatrics in Review. 31(12). 497–505. 17 indexed citations
13.
Rubbert‐Roth, Andrea, P. P. Tak, Cristiano A. F. Zerbini, et al.. (2010). Comment on: Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR): reply. Lara D. Veeken. 50(3). 632–633. 1 indexed citations
14.
Genovese, Mark C., FC Breedveld, P. Emery, et al.. (2009). Safety of biological therapies following rituximab treatment in rheumatoid arthritis patients. Annals of the Rheumatic Diseases. 68(12). 1894–1897. 61 indexed citations
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Uta Engling Poulsen Breakdown of academic impact, for papers by Jesús Tornero-Molina Breakdown of academic impact, for papers by Jeffrey Box Breakdown of academic impact, for papers by Ayanbola Elegbe Breakdown of academic impact, for papers by E. C. Hsia Breakdown of academic impact, for papers by Juan Antonio Martínez-López Breakdown of academic impact, for papers by Victoria Bejarano Breakdown of academic impact, for papers by Hjalmar Wadström Breakdown of academic impact, for papers by E. Keystone Breakdown of academic impact, for papers by Gerd R. Burmester
Rankless by CCL
2026